Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter Shortages Remove Shortages filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (59) Apply European Commission final decision filter CMDh final position (3) Apply CMDh final position filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter Articles 39 and 40 Remove Articles 39 and 40 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 107i procedures (8) Apply Article 107i procedures filter Article 20 procedures (5) Apply Article 20 procedures filter Article 29(4) referrals (1) Apply Article 29(4) referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (5) Apply PRAC-CHMP-EC filter PRAC-CMDh (5) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (5) Apply Centrally and nationally authorised products (mixed) filter Nationally authorised product(s) (10) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (2) Apply Additional monitoring filter Generic (2) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

63 results

Remove all filtersRemove all filters

Medicine Shortages Remove Shortages filter Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Referral type Article 31 referrals Remove Article 31 referrals filter Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter Articles 39 and 40 Remove Articles 39 and 40 filter

Referral safety status Yes Remove Yes filter

Sort by

List item

Referral: Terpenic derivatives

camphor, cineole, niaouli, wild thyme, terpineol, terpine, citral, menthol and essential oils of pine needle, eucalyptus and turpentine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 20/01/2012, Last updated: 13/04/2012
List item

Referral: Pholcodine

Pholcodine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 17/02/2012, Last updated: 28/03/2012
List item

Referral: Dexrazoxane

dexrazoxane, associated names: Cardioxane, Cyrdanax, Dexrazoxane Cyathus, Enaxozar, Procard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 13/09/2011, Last updated: 16/01/2012
List item

Referral: Bisphosphonates

alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011
List item

Referral: Modified-released oral opioids

hydromorphone, morphine and oxycodone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 20/04/2011, Last updated: 06/06/2011
List item

Referral: Valproate

Valproic acid/valproate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 26/08/2010, Last updated: 29/04/2011
List item

Referral: Modafinil

modafinil, associated names: Modasomil, Modiodal, Provigil, Vigil, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 27/01/2011, Last updated: 26/04/2011
List item

Referral: Octagam

human normal immunoglobulin 5% and 10%, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 30/05/2011, Last updated: 26/04/2011
List item

Referral: Dextropropoxyphene

dextropropoxyphene, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 14/06/2010, Last updated: 07/04/2011
List item

Referral: Gadolinium-containing contrast agents

associated names: Omniscan, Magnevist, Magnegita, Gado-MRT ratiopharm, Primovist, MultiHance, Dotarem, ProHance, Gadovist, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 06/12/2010
List item

Referral: Methylphenidate

methylphenidate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 27/05/2009, Last updated: 22/09/2010
List item

Referral: Etoricoxib

etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 21/11/2008
List item

Referral: Norfloxacin

norfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 19/11/2008, Last updated: 24/07/2008
List item

Referral: Ergot-derived dopamine agonists

bromocriptine, cabergoline, dihydroergocryptine, lisuride and pergolide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 26/06/2008
List item

Referral: Piroxicam

piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008
List item

Referral: Agreal

veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008
List item

Referral: Bicalutamide 150 mg

bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007
List item

Referral: Elidel

pimecrolimus, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2006, Last updated: 29/08/2006
List item

Referral: Celecoxib

celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Etoricoxib

etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Lumiracoxib

lumiracoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Paroxetine

Paroxetine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 09/12/2004, EC decision date: 29/03/2005, Last updated: 22/11/2005
List item

Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors

atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005
List item

Referral: Loratadine

loratadine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004
List item

Referral: Loratadine and pseudoephedrine

loratadine / pseudoephedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004

Load more

63 results

Referral: Terpenic derivatives

Referral: Pholcodine

Referral: Dexrazoxane

Referral: Bisphosphonates

Referral: Modified-released oral opioids

Referral: Valproate

Referral: Modafinil

Referral: Octagam

Referral: Dextropropoxyphene

Referral: Gadolinium-containing contrast agents

Referral: Methylphenidate

Referral: Etoricoxib

Referral: Norfloxacin

Referral: Ergot-derived dopamine agonists

Referral: Piroxicam

Referral: Agreal

Referral: Bicalutamide 150 mg

Referral: Elidel

Referral: Celecoxib

Referral: Etoricoxib

Referral: Lumiracoxib

Referral: Paroxetine

Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors

Referral: Loratadine

Referral: Loratadine and pseudoephedrine